Insect Control: Biological and Synthetic Agents - Index of
Insect Control: Biological and Synthetic Agents - Index of
Insect Control: Biological and Synthetic Agents - Index of
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
142 4: <strong>Insect</strong> Growth- <strong>and</strong> Development-Disrupting <strong>Insect</strong>icides<br />
Figure 14 Chemical structures <strong>of</strong> new ecdysone agonists reported in literature: (1) 3,5-di-t-butyl-4-hydroxy-N-isobutyl-benzamide<br />
(DTBHIB) from Sumitomo; (2)8-O-acetylhrapagide from Merck Research Laboratories, Westpoint, PA, USA <strong>and</strong> (3) tetrahydroquinoline<br />
from FMC Corporation, Princeton, NJ, USA. In (3) R ¼ halide.<br />
(DTBHIB; Figure 14) <strong>and</strong> Elbrecht et al. (1996) at<br />
Merck Research Laboratories, Westpoint, PA, USA,<br />
reported the isolation <strong>of</strong> an iridoid glycoside, 8-Oacetylharpagide<br />
(Figure 14), from Ajuga reptans.<br />
Both these compounds were reported to induce<br />
20E-like morphological changes in Drosophila Kc<br />
cells, as well as competitively displace tritiated<br />
ponasterone A from Drosophila ecdysteroid receptors<br />
with potencies similar to that <strong>of</strong> RH-5849, the<br />
unsubstituted bisacylhydrazine. However, the insecticidal<br />
activity <strong>of</strong> these compounds was not<br />
described. Attempts to replicate the results <strong>of</strong><br />
Mikitani (1996) using DTBHIB <strong>and</strong> analogs failed<br />
to demonstrate that these compounds were competitive<br />
inhibitors <strong>of</strong> tritiated ponasterone A binding to<br />
DmEcR/DmUSP produced by in vitro transcription<br />
<strong>and</strong> translation (Dhadialla, unpublished observations).<br />
On the other h<strong>and</strong>, Dinan et al. (2001)<br />
demonstrated that the results obtained by Elbrecht<br />
et al. (1996) were due to co-purification <strong>of</strong> ecdysteroids<br />
in their 8-O-acetylharpagide preparation.<br />
When used as a highly purified preparation, Dinan<br />
et al. (2001) found that 8-O-acetylharpagide was<br />
not active as an agonist or an antagonist in<br />
D. melanogaster BII cell bioassay, <strong>and</strong> neither did<br />
it compete with tritiated ponasterone A for binding<br />
to the lepidopteran ecdysteroid receptor complex<br />
from C. fumiferana.<br />
Finally, scientists at FMC discovered a new<br />
tetrahydroquinoline (THQ) class <strong>of</strong> compounds<br />
(Figure 14) that competitively displaced tritiated<br />
ponasterone A from both dipteran (D. melanogaster)<br />
<strong>and</strong> lepidopteran (H. virescens) EcR <strong>and</strong> USP<br />
heterodimers (unpublished data). Interestingly, the<br />
most active analogs <strong>of</strong> this class <strong>of</strong> compounds<br />
bound the DmEcR/DmUSP with much higher affinity<br />
than the HvEcR/HvUSP. This is the reverse <strong>of</strong><br />
what was observed with bisacylhydrazines. When<br />
tested for lig<strong>and</strong> binding to EcR/USP proteins from<br />
L. migratoria, B. argentifoli, <strong>and</strong> T. molitor, to<br />
which bisacylhydrazines show no measurable<br />
affinity, members <strong>of</strong> the THQ were found to bind<br />
with measurable affinity (mM range; Dhadialla <strong>and</strong><br />
colleagues, unpublished results). Further work on<br />
this chemistry was continued at Rohm <strong>and</strong> Haas<br />
Company, Spring House, PA, USA, <strong>and</strong> its subsidiary,<br />
RheoGene LLC, Malvern, PA, USA, which<br />
resulted in the synthesis <strong>of</strong> a number <strong>of</strong> analogs<br />
that were active in transactivating reporter genes<br />
fused to different insect EcRs <strong>and</strong> heterodimeric<br />
partners (L. migratoria RXR, <strong>and</strong> human RXR) in<br />
mouse NIH3T3 cells (Michelotti et al., 2003).<br />
The discovery <strong>of</strong> THQs with lig<strong>and</strong> binding activities<br />
to various EcRs (Michelotti et al., 2003), some<br />
<strong>of</strong> which do not interact with bisacylhydrazines,<br />
<strong>and</strong> the interpretation <strong>of</strong> X-ray crystal structure<br />
results <strong>of</strong> lig<strong>and</strong>ed HvEcR/HvUSP (Billas et al.,<br />
2003) provides good evidence for the potential to<br />
discover new chemistries with ecdysone agonist<br />
activities. It should also be possible to design chemistries<br />
that specifically interact with EcR/USPs<br />
from a particular insect order.<br />
4.2.9. Noninsecticide Applications <strong>of</strong> Nonsteroidal<br />
Ecdysone Agonists; Gene<br />
Switches in Animal <strong>and</strong> Plant Systems<br />
A number <strong>of</strong> researchers started to explore the utilization<br />
<strong>of</strong> the ecdysone receptor as an inducible gene<br />
switch due to the knowledge that neither mammals<br />
nor plants have ecdysone receptors, <strong>and</strong> the discovery<br />
<strong>of</strong> bisacylhydrazine as true ecdysone agonists<br />
with reduced risk ecotoxicology <strong>and</strong> mammalian<br />
pr<strong>of</strong>iles. Gene switches are inducible gene regulation<br />
systems that can be used to control the expression<br />
<strong>of</strong> transgenes in cells, plants, or animals. There<br />
is a recognized need for tightly regulated eukaryotic<br />
molecular gene switch applications, such as for<br />
gene therapy, <strong>and</strong> in underst<strong>and</strong>ing the role played